scholarly article | Q13442814 |
P50 | author | Eric Hahn | Q57089873 |
Andres H Neuhaus | Q57104099 | ||
P2093 | author name string | Thomas Sander | |
Carolin Opgen-Rhein | |||
Michael Dettling | |||
Carsten Urbanek | |||
P2860 | cites work | Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 |
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain | Q24534089 | ||
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior | Q24671972 | ||
Assessing the molecular genetics of attention networks | Q24792049 | ||
Assessing the heritability of attentional networks | Q24805110 | ||
Testing the efficiency and independence of attentional networks | Q28215562 | ||
The attention system of the human brain | Q28245431 | ||
The activation of attentional networks | Q28251977 | ||
Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex | Q28574634 | ||
Cognitive and emotional influences in anterior cingulate cortex | Q29547440 | ||
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
The development of executive attention: contributions to the emergence of self-regulation. | Q51989057 | ||
Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence | Q52016688 | ||
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. | Q52024529 | ||
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 | ||
Association between the COMT locus and obsessive-compulsive disorder in females but not males | Q57700386 | ||
Re-examining sustained attention deficits as vulnerability indicators for schizophrenia: Stability in the long term course | Q60446623 | ||
The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation | Q69438858 | ||
The "benefits" of distractibility: mechanisms underlying increased Stroop effects in schizophrenia | Q73430980 | ||
Emerging principles of altered neural circuitry in schizophrenia | Q73553170 | ||
D(1) receptors in prefrontal cells and circuits | Q73553186 | ||
Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics | Q74422794 | ||
Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder | Q74626976 | ||
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia | Q78035307 | ||
Selective impairment of attentional networks of orienting and executive control in schizophrenia | Q81194362 | ||
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 | ||
Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study | Q33589568 | ||
The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia | Q33679799 | ||
Genetic and neurochemical modulation of prefrontal cognitive functions in children. | Q34287350 | ||
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction | Q34317550 | ||
Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond | Q34494146 | ||
Schizophrenia and velo-cardio-facial syndrome. | Q34530657 | ||
Dopamine in schizophrenia: a review and reconceptualization | Q34568816 | ||
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine | Q35023131 | ||
Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies | Q35075431 | ||
The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes | Q35860569 | ||
Attentional networks and cingulum bundle in chronic schizophrenia | Q35869136 | ||
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia | Q36500321 | ||
The Mechanism of Action of Novel Antipsychotic Drugs | Q36515345 | ||
Antipsychotic efficacy: relationship to optimal D2-receptor occupancy | Q36785678 | ||
Cognitive control and semantics in schizophrenia: an integrated approach | Q38412002 | ||
Factors influencing Stroop performance in schizophrenia | Q38420753 | ||
The Stroop effect in schizophrenic patients | Q38458217 | ||
Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication | Q38460139 | ||
Cognitive deficits and the neurobiology of schizophrenia. | Q40450297 | ||
Human catechol-O-methyltransferase down-regulation by estradiol | Q40624057 | ||
Impaired attention, genetics, and the pathophysiology of schizophrenia | Q40759066 | ||
Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing | Q42167781 | ||
Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. | Q43858315 | ||
A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition | Q43941587 | ||
Neuropsychological function in schizophrenia. Selective impairment in memory and learning | Q44140683 | ||
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. | Q44174109 | ||
Family‐based and case–control study of catechol‐O‐methyltransferase in schizophrenia among Palestinian Arabs | Q44411867 | ||
Neuropsychological assessment of monozygotic twins discordant for schizophrenia | Q44455966 | ||
Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia | Q44578270 | ||
Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. | Q44750292 | ||
Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families | Q44868288 | ||
Effect of catechol-O-methyltransferase val158met genotype on attentional control. | Q46497177 | ||
What does the PANSS mean? | Q46570213 | ||
Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: tuning rather than improving performance | Q46681227 | ||
Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription | Q47952194 | ||
Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior | Q48052397 | ||
Postnatal alterations in dopaminergic markers in the human prefrontal cortex | Q48360019 | ||
Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study. | Q48435140 | ||
Brain regions underlying response inhibition and interference monitoring and suppression | Q48453455 | ||
Impact of complex genetic variation in COMT on human brain function | Q48492697 | ||
Development of attentional networks in childhood. | Q48549106 | ||
Anterior cingulate cortex activation during cognitive interference in schizophrenia. | Q51942045 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
attention | Q6501338 | ||
P304 | page(s) | 1231-1239 | |
P577 | publication date | 2008-01-16 | |
P1433 | published in | Schizophrenia Bulletin | Q4049133 |
P1476 | title | Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test | |
P478 | volume | 34 |
Q34591845 | Antipsychotic medications and cognitive functioning in bipolar disorder: moderating effects of COMT Val108/158 Met genotype |
Q43442662 | Attention Network Test reveals alerting network dysfunction in multiple sclerosis |
Q53144537 | Attentional alterations in alcohol dependence are underpinned by specific executive control deficits. |
Q34157001 | COMT Val158Met polymorphism, cognitive stability and cognitive flexibility: an experimental examination |
Q35053457 | COMT and ALDH2 polymorphisms moderate associations of implicit drinking motives with alcohol use. |
Q37284307 | COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation |
Q38987880 | Differential impairments across attentional networks in binge drinking. |
Q44490894 | Effects of a CACNA1C genotype on attention networks in healthy individuals |
Q35982278 | Evidence of IQ-modulated association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients |
Q31098898 | Executive attention impairment in first-episode schizophrenia |
Q51737708 | Gene polymorphisms and response to transcranial direct current stimulation for auditory verbal hallucinations in schizophrenia. |
Q34410670 | Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission. |
Q36248985 | Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia |
Q45407251 | Inferior frontal white matter asymmetry correlates with executive control of attention |
Q36353466 | Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults. |
Q46575862 | Neural correlates of the attention network test in schizophrenia |
Q33937051 | Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. |
Q38765239 | Schizophrenia: genetics, prevention and rehabilitation |
Q35679951 | The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder |
Q45157471 | ZNF804A may be associated with executive control of attention |
Q50975311 | [Schizophrenia, genetics and cognition]. |
Search more.